1. Home
  2. SAMG vs OBIO Comparison

SAMG vs OBIO Comparison

Compare SAMG & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAMG
  • OBIO
  • Stock Information
  • Founded
  • SAMG 2002
  • OBIO 2017
  • Country
  • SAMG United States
  • OBIO United States
  • Employees
  • SAMG N/A
  • OBIO N/A
  • Industry
  • SAMG Investment Managers
  • OBIO Medicinal Chemicals and Botanical Products
  • Sector
  • SAMG Finance
  • OBIO Health Care
  • Exchange
  • SAMG Nasdaq
  • OBIO Nasdaq
  • Market Cap
  • SAMG 149.2M
  • OBIO 151.3M
  • IPO Year
  • SAMG 2013
  • OBIO N/A
  • Fundamental
  • Price
  • SAMG $14.78
  • OBIO $2.85
  • Analyst Decision
  • SAMG
  • OBIO Strong Buy
  • Analyst Count
  • SAMG 0
  • OBIO 5
  • Target Price
  • SAMG N/A
  • OBIO $15.00
  • AVG Volume (30 Days)
  • SAMG 72.9K
  • OBIO 69.1K
  • Earning Date
  • SAMG 05-01-2025
  • OBIO 05-12-2025
  • Dividend Yield
  • SAMG 5.40%
  • OBIO N/A
  • EPS Growth
  • SAMG 4.17
  • OBIO N/A
  • EPS
  • SAMG 1.00
  • OBIO N/A
  • Revenue
  • SAMG $123,651,000.00
  • OBIO $2,638,000.00
  • Revenue This Year
  • SAMG $9.70
  • OBIO $27.37
  • Revenue Next Year
  • SAMG $7.28
  • OBIO $42.68
  • P/E Ratio
  • SAMG $14.78
  • OBIO N/A
  • Revenue Growth
  • SAMG 5.32
  • OBIO N/A
  • 52 Week Low
  • SAMG $14.12
  • OBIO $2.49
  • 52 Week High
  • SAMG $19.20
  • OBIO $8.87
  • Technical
  • Relative Strength Index (RSI)
  • SAMG 32.30
  • OBIO 36.86
  • Support Level
  • SAMG $14.26
  • OBIO $2.75
  • Resistance Level
  • SAMG $15.92
  • OBIO $3.26
  • Average True Range (ATR)
  • SAMG 0.70
  • OBIO 0.48
  • MACD
  • SAMG -0.01
  • OBIO -0.01
  • Stochastic Oscillator
  • SAMG 22.13
  • OBIO 16.82

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: